Cancer cells 'talk' to their environment, and it talks back

A Cornell-led team has devised a method for measuring the mechanical force cells exert on their surroundings, which can help scientists design better biomaterial scaffolds for tissue engineering.

Barrett, Leibovich and Walsh named AAAS fellows for 2016

Three faculty members - development economist Chris Barrett, mechanical engineer Sidney Leibovich and medical mycologist Dr. Thomas Walsh - have been named fellows of the American Association for the Advancement of Science.

NYC high schoolers discover opportunity at Big Red STEM Day

The first Big Red STEM Day exposed high school students from communities underrepresented in science, technology, engineering and mathematics to educational and career opportunities in those fields.

Cells implicated in dementia related to high blood pressure

High blood pressure transforms cells of the immune system that reside around cerebral blood vessels and normally protect the brain into agents of cognitive decline, according to new research from Weill Cornell Medicine scientists.

Weill Cornell partners in innovative drug discovery company

Memorial Sloan Kettering Cancer Center, The Rockefeller University and Weill Cornell Medicine announced Oct. 31 that they have established a new drug discovery company called Bridge Medicines.

$2M gift to drive Weill Cornell advances in immunotherapy

To advance a powerful cancer treatment strategy that uses immune cells to fight the disease, Ellen and Gary Davis '76 have made a $2 million gift to Weill Cornell Medicine to drive ongoing research in immunotherapy.

Researchers, alums receive NIH New Innovator Awards

Two Cornell researchers and two alumni were among 48 scientists nationwide who received $1.5 million awards from the National Institutes of Health.

Research project to combat 'superbugs,' antibiotic resistance

Cornell researchers received a $500,000 grant from the Centers for Disease Control and Prevention to help in a national initiative to combat drug-resistant organisms, sometimes referred to as "superbugs."

Chemotherapy drives bladder cancer treatment resistance

New research by Weill Cornell Medicine shows chemotherapy kills the most common type of bladder cancer, urothelial cancer, but it also shapes genetic evolution of remaining urothelial cancer cells.